Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Alpha Cognition Inc.
Alpha Cognition Files U.S. Patent Application Covering an ALPHA-1062 Oral Formulation to Treat Mild to Moderate Alzheimer’s Disease
February 22, 2024
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
CSE:ACOG
Alpha Cognition Provides Business Update
February 12, 2024
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
CSE:ACOG
Alpha Cognition Announces Final Closing of Private Placement Offering and Completion of the Overallotment
January 19, 2024
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
CSE:ACOG
Alpha Cognition Announces Fourth Closing of Private Placement and Continuation of the Offering
December 22, 2023
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
CSE:ACOG
Alpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease
December 07, 2023
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
CSE:ACOG
Alpha Cognition Announces Amended Terms of Private Placement and Continuation of the Offering
December 04, 2023
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
CSE:ACOG
Alpha Cognition Announces Second Closing of Private Placement and Continuation of the Offering
October 16, 2023
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
CSE:ACOG
Alpha Cognition Announces Initial Closing of Private Placement and Pricing for Continuation of the Offering
August 31, 2023
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
CSE:ACOG
Alpha Cognition Launches $6.5 Million Private Placement
May 30, 2023
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
CSE:ACOG
Alpha Cognition Announces Fourth Quarter and Full Year 2022 Results and Provides Corporate Update
March 08, 2023
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
TSX:ACOG
Alpha Cognition Provides Private Placement Update
March 06, 2023
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
TSX-V:ACOG
Alpha Cognition Announces Third Quarter 2022 Results and Provides Corporate Update
November 28, 2022
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
TSX-V:ACOG
Alpha Cognition Announces Second Quarter 2022 Results and Provides Corporate Update
August 25, 2022
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
TSX-V:ACOG
Alpha Cognition Announces Positive Topline Results from Bioequivalence Study with ALPHA-1062 in Development for Alzheimer’s Disease
August 22, 2022
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
TSX-V:ACOG
Alpha Cognition Announces Positive Results from Pivotal Study with ALPHA-1062 in Development for Alzheimer’s Disease
June 22, 2022
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
TSX-V:ACOG
Alpha Cognition Announces Successful Defense of European Patent Covering ALPHA-0602
June 15, 2022
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
TSX-V:ACOG
Alpha Cognition Announces Positive Data from Pre-Clinical Studies and Discovery of GEM Combinations with Potential for Neurodegenerative Disease Treatment
June 13, 2022
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
TSX-V:ACOG
Alpha Cognition Announces Grant of Stock Options
May 31, 2022
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
TSX-V:ACOG
Alpha Cognition Announces First Quarter 2022 Results and Company Update
May 31, 2022
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
TSX-V:ACOG
Alpha Cognition Announces Fourth Quarter and Full Year 2021 Results and Company Update
April 28, 2022
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
TSX-V:ACOG
Alpha Cognition Announces Change of CFO, Grant of Stock Options and Addition to the Board of Directors
April 12, 2022
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
TSX-V:ACOG
Alpha Cognition Announces Positive Data from Pre-Clinical Studies of ALPHA-0602 (Progranulin) for Amyotrophic Lateral Sclerosis (ALS)
March 29, 2022
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
Alpha Cognition Announces Positive Neuroprotection Data from Pre-Clinical Study of ALPHA-1062 for Traumatic Brain Injury
February 22, 2022
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
Alpha Cognition Announces Participation in January Investor Conferences
January 03, 2022
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
Alpha Cognition Announces Director Change and Stock Option Grant
December 27, 2021
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
Alpha Cognition Announce Data from Pre-Clinical Study of ALPHA-1062 for Traumatic Brain Injury
December 06, 2021
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
Alpha Cognition Appoints Cedric O’Gorman, M.D., MBA as Chief Medical Officer
December 02, 2021
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
Alpha Cognition Reports Third Quarter of Fiscal 2021 Results
November 30, 2021
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
Alpha Cognition to Present at LD Micro Main Event
October 08, 2021
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
Alpha Cognition Provides CEO Update
October 07, 2021
From
Alpha Cognition Inc.
Via
Business Wire
Tickers
ACOGF
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.